Categories: News

Aussie LegalTech Startup Goes Global With COVID-19 Diagnosis Tool

  • Australian LegalTech startup, Rulestar, is taking its automation platform global and expanding beyond the legal industry.
  • Rulestar has released an automated COVID-19 diagnosis tool as a new proof-of-concept product.
  • This demonstrates how automation technologies can improve decision-making across industries.

SYDNEY, May 25, 2021 /PRNewswire/ — An Australian startup is demonstrating how its software, built to automate complex legal documents, can improve COVID-19 decision-making. Rulestar has converted a complex, static flowchart from an academic article into a dynamic online tool designed for anyone to use. Their automated COVID-19 diagnosis tool is made available online for demonstration purposes through the Rulestar website (see https://rulestar.com/demo-product).

Rulestar was inspired to build this new product by seeing frontline workers stretched beyond capacity in devastated countries like the USA and India. “We looked up what’s involved in triaging a potential Coronavirus patient: the logic isn’t simple”, says David Lipworth, Rulestar’s Managing Director. “We figured that it’s dangerous to expect exhausted and stressed-out frontline workers to follow something like that”.

The example aims to show that automation can not only increase the speed of decision-making but also, and more importantly, improve the quality of decisions. Driven by this COVID-19 use case, the company is now taking its platform global and making it available for ‘DIY’ automation across all industries.

About Rulestar

Rulestar (https://rulestar.com) is a no-code platform for automating decisions and documents. At the heart of the technology is a powerful logic engine, with a graphical logic builder, which makes automation with complex logical rules accessible for non-developers.

Download images here:

Rulestar logo
Caption: “Rulestar (https://rulestar.com) is a new, no-code platform for automating decisions and documents.”

Laptop showing COVID-19 diagnosis tool
Caption: “Rulestar’s automated COVID-19 diagnosis tool is made available online for demonstration purposes at https://rulestar.com/demo-product.”

Complex academic flowchart
Caption: “Rulestar (https://rulestar.com) turned this complex, static flowchart from an academic article about COVID-19 diagnosis into a dynamic online tool that anyone can use.”

 

View original content:http://www.prnewswire.com/news-releases/aussie-legaltech-startup-goes-global-with-covid-19-diagnosis-tool-301296711.html

SOURCE Rulestar

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

1 hour ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

15 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

16 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

16 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

17 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

19 hours ago